IPO Boutique Brief: July 13th IPO Launch Party — Biotechs set terms for busy week (FREE)

Below is a list of IPOs that set terms this morning (07/13/20) and will debut in the same week. IPO Boutique provides research, color, commentary and rating on all IPOs.

Company: Renalytix AI plc
Symbol:RNLX
Description: They are an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and lower healthcare costs. Their ordinary shares trade on AIM, a market operated by the London Stock Exchange, under the symbol “RENX.”
Shares: 5.5 million ADSs (represented by 11.0mm ordinary shares)
Price Range: $14.22-$14.22
Market Cap: $501m-$501m
Trade Date: Friday, 7/17
Underwriter(s): JP Morgan, Stifel
Terms Added: 7-13-20

Company: Pandion Therapeutics, Inc.
Symbol: PAND
Description: They are a clinical stage biopharmaceutical company developing novel therapeutics designed to address the unmet needs of patients suffering from autoimmune diseases.
Shares: 5.5 million
Price Range: $16.00-$18.00
Market Cap: $423m-$477m
Trade Date: Friday, 7/17
Underwriter(s): Goldman Sachs, Morgan Stanley, SVB Leerink, BMO Capital Markets
Terms Added: 7-13-20

Company: Berkeley Lights, Inc.
Symbol: BLI
Description: Berkeley Lights is a leading Digital Cell Biology company focused on enabling and accelerating the rapid development and commercialization of biotherapeutics and other cell-based products.
Shares: 7.4 million
Price Range: $16.00-$18.00
Market Cap: $975m-$1.1bn
Trade Date: Friday, 7/17
Underwriter(s): JP Morgan, Morgan Stanley, Cowen
Co-Manager: William Blair
Terms Added: 7-13-20

Company: ACell Inc.
Symbol: ACLL
Description: They are a leading regenerative medicine company focused on the development, manufacture and sale of products primarily used in acute care settings as part of the treatment and management of moderate to severe wounds and reinforcement of soft tissue surgical defects.
Shares: 5 million
Price Range: $14.00-$16.00
Market Cap: $317m-$363m
Trade Date: Friday, 7/17
Underwriter(s): UBS Investment Bank, Barclays, RBC Capital Markets
Co-Manager: SunTrust Robinson Humphrey
Terms Added: 7-13-20

Company: ALX Oncology Holdings Inc.
Symbol: ALXO
Description: They are a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block the CD47 checkpoint pathway and bridge the innate and adaptive immune system.
Shares: 8 million
Price Range: $15.00-$17.00
Market Cap: $521m-$590m
Trade Date: Friday, 7/17
Underwriter(s): Jefferies, Credit Suisse, Piper Sandler, Cantor
Co-Manager: Life Sciences Advisors
Terms Added: 7-13-20